메뉴 건너뛰기




Volumn 78, Issue 3, 1998, Pages 261-263

Obesity in 21-hydroxylase deficient patients

Author keywords

Adiposity rebound; Body mass index; Congenital adrenal hyperplasia

Indexed keywords

ARTICLE; BODY HEIGHT; BODY MASS; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MALE; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STEROID 21 MONOOXYGENASE DEFICIENCY; UNITED KINGDOM;

EID: 0031901135     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.78.3.261     Document Type: Article
Times cited : (102)

References (8)
  • 1
    • 0024242503 scopus 로고
    • Persistent obesity and short final height after corticoid over-treatment for congenital adrenal hyperplasia in infancy
    • Knorr D, Hinrichsen de Lienan SGC. Persistent obesity and short final height after corticoid over-treatment for congenital adrenal hyperplasia in infancy. Acta Pacdiatr Jpn 1988;30:89-92.
    • (1988) Acta Pacdiatr Jpn , vol.30 , pp. 89-92
    • Knorr, D.1    Hinrichsen De Lienan, S.G.C.2
  • 3
    • 0021335136 scopus 로고
    • Adiposity rebound in children: A simple indicator for predicting obesity
    • Rolland-Cachera MF, Deheeger M, Bellisle F, et al. Adiposity rebound in children: a simple indicator for predicting obesity. Am J Clin Nutr 1984;39:129-35.
    • (1984) Am J Clin Nutr , vol.39 , pp. 129-135
    • Rolland-Cachera, M.F.1    Deheeger, M.2    Bellisle, F.3
  • 4
    • 0024438361 scopus 로고
    • Monitoring treatment in congenital adrenal hyperplasia
    • Appan S, Hindmarsh PC, Brook CGD. Monitoring treatment in congenital adrenal hyperplasia. Arch Dis Child 1989;64:1235-9.
    • (1989) Arch Dis Child , vol.64 , pp. 1235-1239
    • Appan, S.1    Hindmarsh, P.C.2    Brook, C.G.D.3
  • 5
    • 0031025507 scopus 로고    scopus 로고
    • Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency)
    • Gasparini N, Di Maio S, Salerno M, et al. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency). Horm Res 1997; 47:17-22.
    • (1997) Horm Res , vol.47 , pp. 17-22
    • Gasparini, N.1    Di Maio, S.2    Salerno, M.3
  • 6
    • 0029082974 scopus 로고
    • Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): Relation to body mass index in earlier childhood
    • Yu ACM, Grant DB. Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood. Acta Paediatr 1995;84:899-903.
    • (1995) Acta Paediatr , vol.84 , pp. 899-903
    • Yu, A.C.M.1    Grant, D.B.2
  • 7
    • 0030841702 scopus 로고    scopus 로고
    • Hydrocortisone replacement therapy in children and adolescents with hypopituitarism
    • De Vile CJ, Stanhope R. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism. Clin Endocrinol (Oxf) 1997;47:37-41.
    • (1997) Clin Endocrinol (Oxf) , vol.47 , pp. 37-41
    • De Vile, C.J.1    Stanhope, R.2
  • 8
    • 0029795514 scopus 로고    scopus 로고
    • The use of adrenalectomy as a treatment for congenital adrenal hyperplasia
    • Van Wyk JJ, Gunther DF, Ritzen EM, et al. The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1996;81:3180-90.
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 3180-3190
    • Van Wyk, J.J.1    Gunther, D.F.2    Ritzen, E.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.